Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Change in Cash: 2011-2024

Historic Change in Cash for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $22.4 million.

  • Mimedx Group's Change in Cash rose 17.46% to $23.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.3 million, marking a year-over-year increase of 597.68%. This contributed to the annual value of $22.4 million for FY2024, which is 39.66% up from last year.
  • Latest data reveals that Mimedx Group reported Change in Cash of $22.4 million as of FY2024, which was up 39.66% from $16.1 million recorded in FY2023.
  • Over the past 5 years, Mimedx Group's Change in Cash peaked at $26.7 million during FY2020, and registered a low of -$21.1 million during FY2022.
  • Over the past 3 years, Mimedx Group's median Change in Cash value was $16.1 million (recorded in 2023), while the average stood at $5.8 million.
  • Per our database at Business Quant, Mimedx Group's Change in Cash slumped by 142.10% in 2022 and then spiked by 175.95% in 2023.
  • Yearly analysis of 5 years shows Mimedx Group's Change in Cash stood at $26.7 million in 2020, then crashed by 132.64% to -$8.7 million in 2021, then slumped by 142.10% to -$21.1 million in 2022, then soared by 175.95% to $16.1 million in 2023, then soared by 39.66% to $22.4 million in 2024.